Article

Antibody-guided brachytherapy appears effective

Cleveland-Immunoscintigraphy scanning, criticized in the past for poor performance in imaging metastatic disease, may have found a reliable niche in the treatment of prostate cancer.

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Strategies to bridge gender disparities in AAS and citations in the oncology literature
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
Shot of a doctor showing a patient some information on a digital tablet | Image Credit | © bongkarn - stock.adobe.com
OnabotA for OAB: Enhancing comfort and ensuring adherence
Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
Reflecting on NMIBC Progress: Highlights From AUA 2025 and What’s Ahead
Reflecting on NMIBC Progress: Highlights From AUA 2025 and What’s Ahead
Navigating Access Barriers: Resources to Support New Treatment Access
Navigating Access Barriers: Resources to Support New Treatment Access
Overcoming Challenges in Accessing New Therapies for NMIBC
Overcoming Challenges in Accessing New Therapies for NMIBC
Stacy Loeb, MD, MSc, PhD (Hon), answers a question during a Zoom video interview
Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
Maria Uloko, MD, on the need for better education on female sexual dysfunction
Maria Uloko, MD, on the need for better education on female sexual dysfunction
Dean Elterman, MD, on the shift toward personalized care in BPH
Dean Elterman, MD, on the shift toward personalized care in BPH
Related Content
PSMA-PET imaging product, Gozellix, launches on US market
June 11th 2025

PSMA-PET imaging product, Gozellix, launches on US market

Hannah Clarke
Gozellix was approved by the FDA in March 2025.
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD
Dipen Parekh, M.D. named Chief Executive Officer of the University of Miami Health System
June 11th 2025

Dipen Parekh, M.D. named Chief Executive Officer of the University of Miami Health System

University of Miami Health System Desai Sethi Urology Institute
Award-winning COO of UHealth, renowned surgeon scientist, and director of the Desai Sethi Urology Institute elevated to lead patient-focused care, biomedical research, and medical education
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
Adding cetrelimab to niraparib maintenance shows benefit in aggressive variant prostate cancer
June 11th 2025

Adding cetrelimab to niraparib maintenance shows benefit in aggressive variant prostate cancer

Hannah Clarke
However, this regimen was associated with substantial toxicity, so careful patient selection is paramount, according to the authors.
Suzanne B. Merrill, MD, FACS
June 10th 2025

Urologists discuss managing NMIBC amidst BCG shortages

Urology Times staff
A major challenge addressed in the Clinical Forum was managing BCG shortages and the implications for patient care.
© 2025 MJH Life Sciences

All rights reserved.